ERBB2 and breast carcinoma: In particular, DHADA and EPADA arrested cell cycle and reduced concomitantly S-phase in MCF-7, SK-BR-3 and MDA-MB-231 cells, indicating that these molecules induced cell cycle arrest in breast cancer cells, independently of ER/PR/HER2 status [70].